# Lerner et al. (2010) - Subset-Directed Antivirals in 142 CFS Patients

**Largest and most comprehensive Lerner cohort study on antiviral therapy in ME/CFS**

## Study Summary

Prospective cohort study following 142 CFS patients at one clinic from 2001-2007, receiving subset-directed antiviral therapy (valacyclovir and/or valganciclovir) based on herpesvirus serology. Patients stratified into groups: Group A (single infection), Group B (co-infections), Group C (controls).

## Key Results

- **Group A (single infection):** Highly significant improvement (P=0.0001)
- **Energy Index Point Scale:** Significant increase (P<0.0001)
- **Response rate:** 30-40% in appropriately selected patients
- **Herpesvirus prevalence:** EBV involved in 81% of cases
- **Co-infections:** Poorer response to single-agent therapy

## Citation

Lerner AM, Beqaj SH, Fitzgerald JT, Gill K, Gill C, Edington J. Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome. *Virus Adapt Treat*. 2010;2:47-57. doi:10.2147/VAAT.S10695

**BibTeX key:** `Lerner2010antivirals`

## Files in This Folder

- `abstract.txt` - Full abstract and metadata
- `notes.md` - Detailed analysis and methodology
- `key-findings.md` - Main findings and clinical implications
- `README.md` - This file

## Evidence Quality

**MEDIUM-HIGH** - Large prospective cohort with long-term follow-up (not RCT)

## Clinical Relevance

This study provides the most comprehensive real-world evidence for subset-directed antiviral therapy in ME/CFS. The large sample size (n=142) and long follow-up period (2001-2007) offer valuable insights into long-term treatment outcomes. However, the observational design and selection bias (single specialized clinic) limit causal inference.

The finding that co-infections respond poorly to single-agent therapy has important clinical implications for treatment planning.

## Integration Status

- Added to `/home/nicky/code/health-me-cfs/references.bib` âœ“
- Ready for citation in Chapter 15 (Medications - Antivirals)
- Provides foundation for subset-directed therapy approach
